Cargando…
546. COVID-19 Monoclonal Antibody Use at a Stand Alone Children’s Hospital
BACKGROUND: Texas Children’s Hospital (TCH) implemented an outpatient clinic for eligible patients to receive infusions when COVID monoclonal antibodies (mAbs) were approved for use in non-hospitalized, high-risk patients with mild to moderate COVID-19. There are limited data evaluating the use of o...
Autores principales: | Stimes, Grant T, Rodriguez, Brittany, Gillispie, Amanda, Hilliard, Tanya J, Munoz, Flor M, Satter, Lisa Forbes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676883/ http://dx.doi.org/10.1093/ofid/ofad500.615 |
Ejemplares similares
-
544. Outpatient Remdesivir Use at a Stand Alone Children's Hospital
por: Rodriguez, Brittany, et al.
Publicado: (2023) -
546. No Difference in MK-8591 and Doravirine Pharmacokinetics After Co-Administration
por: Matthews, Randolph, et al.
Publicado: (2018) -
1507. Pharmacodynamic Target Attainment of Daptomycin Against Staphylococcus aureus for Treatment of Pediatric Osteomyelitis
por: Stimes, Grant, et al.
Publicado: (2019) -
546 Health Disparities Among Rural Burn Patients
por: Duggan, Robert P, et al.
Publicado: (2022) -
546. Capturing Clinician’s Experiences Repurposing Drugs to Inform Future Studies During COVID-19
por: Duggal, Mili, et al.
Publicado: (2020)